MRI Breast Without IV Contrast There is no relevant literature to support the use of MRI breast without IV contrast for screening in this clinical scenario. Sestamibi MBI There is no relevant literature to support the use of Tc-99m sestamibi MBI in this clinical scenario. Imaging after Breast Surgery Variant 3: Adult female younger than 30 years of age. Postsurgical excision with nonmalignant pathology. Asymptomatic. Initial imaging. Benign breast disease can be classified into 3 broad categories: nonproliferative lesions, proliferative lesions without atypia, and proliferative lesions with atypia. Nonproliferative lesions include benign calcifications, fibrocystic changes, fibroadenomas, lipomas, fat necrosis, and nonsclerosing adenosis. Proliferative lesions without atypia include usual ductal hyperplasia, sclerosing adenosis, complex fibroadenomas, radial scars/complex sclerosing lesions, papillomas, and papillomatosis. Proliferative lesions with atypia include atypical ductal hyperplasia, atypical lobular hyperplasia, LCIS, and flat epithelial atypia [4,5]. Benign breast disease and breast tissue density are independent risk factors for developing breast cancer [5,6]. One study of women from the BCSC reported breast cancer in 25% of women with excision for proliferative lesions with atypia [7]. Almost 30% of women with breast cancer have a history of benign breast disease [4]. FDG-PET Breast Dedicated There is no relevant literature to support the use of FDG-PET breast in this clinical scenario. MRI Breast Without and With IV Contrast There is no relevant literature to support the routine use of MRI breast without and with IV contrast in an average- risk patient. Some benign breast disease, especially atypical ductal hyperplasia and lobular neoplasia can increase Imaging after Breast Surgery MRI Breast Without IV Contrast There is no relevant literature to support the use of MRI breast without IV contrast for screening in this clinical scenario.
Imaging after Breast Surgery. MRI Breast Without IV Contrast There is no relevant literature to support the use of MRI breast without IV contrast for screening in this clinical scenario. Sestamibi MBI There is no relevant literature to support the use of Tc-99m sestamibi MBI in this clinical scenario. Imaging after Breast Surgery Variant 3: Adult female younger than 30 years of age. Postsurgical excision with nonmalignant pathology. Asymptomatic. Initial imaging. Benign breast disease can be classified into 3 broad categories: nonproliferative lesions, proliferative lesions without atypia, and proliferative lesions with atypia. Nonproliferative lesions include benign calcifications, fibrocystic changes, fibroadenomas, lipomas, fat necrosis, and nonsclerosing adenosis. Proliferative lesions without atypia include usual ductal hyperplasia, sclerosing adenosis, complex fibroadenomas, radial scars/complex sclerosing lesions, papillomas, and papillomatosis. Proliferative lesions with atypia include atypical ductal hyperplasia, atypical lobular hyperplasia, LCIS, and flat epithelial atypia [4,5]. Benign breast disease and breast tissue density are independent risk factors for developing breast cancer [5,6]. One study of women from the BCSC reported breast cancer in 25% of women with excision for proliferative lesions with atypia [7]. Almost 30% of women with breast cancer have a history of benign breast disease [4]. FDG-PET Breast Dedicated There is no relevant literature to support the use of FDG-PET breast in this clinical scenario. MRI Breast Without and With IV Contrast There is no relevant literature to support the routine use of MRI breast without and with IV contrast in an average- risk patient. Some benign breast disease, especially atypical ductal hyperplasia and lobular neoplasia can increase Imaging after Breast Surgery MRI Breast Without IV Contrast There is no relevant literature to support the use of MRI breast without IV contrast for screening in this clinical scenario.